Potential drug‐drug interactions associated with drugs currently proposed for COVID‐19 treatment in patients receiving other treatments

摘要

Pharmacologists, pharmacists and other drug experts have been at the forefront during the COVID‐19 outbreak. Pharmacological expertise was required in various areas such as the daily healthcare of patients admitted to our hospitals [1], the implementation of pharmacokinetic and pharmacokinetic‐pharmacodynamic studies in clinical trials of repurposed drugs [2] and even in providing up‐to‐date information to the general population [3].